insights_auto
Why is GMAB up 5.32%?
Dive Deeperchevron_right
GMAB:CPH
Genmab A/S
DKK 2,377.00
arrow_upward
+5.32%(+120.00) 1D
Oct 5, 5:00:00 PM GMT+2 · DKK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GMAB...
Open
DKK 2,323.00
High
DKK 2,405.00
Low
DKK 2,310.00
Mkt. cap
140.71B
Avg. vol.
112.20K
Volume
209.10K
52-wk high
DKK 2,405.00
52-wk low
DKK 1,512.00
Shares outstanding
62.41M
No. of employees
3K
Open
DKK 2,323.00
High
DKK 2,405.00
Low
DKK 2,310.00
Mkt. cap
140.71B
Avg. vol.
112.20K
Volume
209.10K
52-wk high
DKK 2,405.00
52-wk low
DKK 1,512.00
Shares outstanding
62.41M
No. of employees
3K
News stories
From web sources and news partners
Investing.com
·
49 minutes ago
Why is Genmab stock surging today?
TradingKey
·
54 minutes ago
Genmab A/S Stock (GMAB) Moved Up by 13.01% on Oct 5: Key Drivers Unveiled
Investing.com
·
1 hour ago
Genmab stock surges 11% on positive cancer drug trial data
Stock Titan
·
1 hour ago
A lymphoma drug combination cut the risk of worsening or death by 51% in a trial.
Profile
Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, The Netherlands, Genmab U.S., Inc. in Princeton, New Jersey, US, Genmab K.K. in Tokyo, Japan, Genmab Germany GmbH in München, Germany and Genmab Co., Ltd. in Suzhou, China. Genmab is listed on the Copenhagen Stock Exchange in Denmark, with American depositary receipts traded on the NASDAQ in the US. Wikipedia
About Genmab A/S
CEOJan G. J. van de Winkel
Employees3.12K
FoundedJun 11, 1998
Headquarters-
SectorBiotechnology
Websitegenmab.com